Pregnant women with suspected Zika virus infection: A claims data analysis


Zika virus disease and Zika virus congenital infection are nationally notifiable conditions that became prominent recently as a growing number of travel-associated infections have been identified in the United States. The Centers for Disease Control and Prevention (CDC) have dedicated significant time and effort on determining and addressing the risks and impact of Zika on pregnant women and their babies who are most vulnerable to the disease. CDC relies on two sources of information, reported voluntarily by healthcare providers, to monitor Zika virus disease: ArboNET and the newly established U.S. Zika Pregnancy Registry. A study by IMS Health compared U.S.trends of the Zika virus disease in general and pregnant women with Zika virus disease in particular observed in an IMS healthcare claims database and the CDC ArboNET and the newly established U.S. ZikaPregnancy Registry.


Demonstrate the value of consolidated claims data from community healthcare providers in Zika Virus Disease surveillance at local level.

Primary Topic Areas: 
Original Publication Year: 
Event/Publication Date: 
December, 2016

August 03, 2017

Contact Us

NSSP Community of Practice



This website is supported by Cooperative Agreement # 6NU38OT000297-02-01 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health between the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. CDC is not responsible for Section 508 compliance (accessibility) on private websites.

Site created by Fusani Applications